Health-related Quality of Life in Localized and Metastatic Renal Cell Carcinoma: Insights from Patient-reported Outcome Measures

We looked at health-related quality of life (HRQoL) in patients with localized or metastatic kidney cancer. In general, both groups reported improvements in emotional, social, and physical wellbeing at 15 weeks after their diagnosis, and results suggest further changes at 6 months after diagnosis. Patients reported improvements in symptoms such as fatigue, pain, sleep, and appetite. Our results indicate that patients can find meaningful improvements in their quality of life shortly after diagnosis and initiation of treatment.

Authors

Institutions

Publication Details

Journal
European Urology Open Science
Published
2026-01-21
DOI
https://doi.org/10.1016/j.euros.2025.12.017
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-related Quality of Life in Localized and Metastatic Renal Cell Carcinoma: Insights from Patient-reported Outcome Measures

Katja K.H. Aben, Hilin Yildirim, Maureen J.B. Aarts, Patricia Zondervan et al.
European Urology Open Science
Renal cell carcinoma treatment
article

Health-related Quality of Life in Localized and Metastatic Renal Cell Carcinoma: Insights from Patient-reported Outcome Measures

Katja K.H. Aben, Hilin Yildirim, Maureen J.B. Aarts, Patricia Zondervan, Corina van den Hurk, Arnoud W. Postema, Martijn G.H. van Oijen, Matthijs Duijn, Adriaan D. Bins
article en

Abstract

We looked at health-related quality of life (HRQoL) in patients with localized or metastatic kidney cancer. In general, both groups reported improvements in emotional, social, and physical wellbeing at 15 weeks after their diagnosis, and results suggest further changes at 6 months after diagnosis. Patients reported improvements in symptoms such as fatigue, pain, sleep, and appetite. Our results indicate that patients can find meaningful improvements in their quality of life shortly after diagnosis and initiation of treatment.

European Urology Open ScienceVol. 84
Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Radboud University Medical Center (NL), Santeon (Netherlands) (NL), Netherlands Comprehensive Cancer Organisation (NL), Amsterdam University Medical Centers (NL), University of Amsterdam (NL)
Openalex Percentile: Top 81%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.